EX PARTE APPEAL PENDING
on 05 Dec 2024
Last Applicant/ Owned by
3030 Bunker Hill St. Suite 117D
San Diego
CA
92109
Serial Number
97680953 filed on 16th Nov 2022
Registration Number
N/A
Correspondent Address
JOHN W. OLIVO, JR.
JOHN W. OLIVO, JR. OLIVO IP LAW GROUP, P.C.
C/O OLIVO IP GROUP, INC.
BEVERLY HILLS, CA 90210
UNITED STATES
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
EXOKERYX
DNA, RNA, protein, lipid, metabolite, biomarker analysis services in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medic Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
DNA, RNA, protein, lipid, metabolite, biomarker analysis services in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease. Providing on-line non-downloadable computer search engine software for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease; providing online non-downloadable computer software for the custom design and ordering of assays and reagents in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease. Scientific laboratory services; Medical laboratory services; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of onsite management of information technology (IT) systems of others that allows users to store, analyze and share information over a global computer network in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, food safety, agriculture, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease
First Use Date in General
13th Oct 2021
First Use Date in Commerce
15th Nov 2021
Class [005]
Pharmaceutical Products
Kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for in vitro diagnostic use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for veterenary use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for clinical use; kits, comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffers, nucleic acids, biological agents, and assays, for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease for medical purposes
First Use Date in General
13th Oct 2021
First Use Date in Commerce
15th Nov 2021
Class [001]
Chemical Products
Kits comprising reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, for scientific, non-medical, or medical research use; Kits comprising reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, and assays, conjugation chemistries, and chemical groups for scientific or medical research use; kits, reagents, enzymes, enzyme substrates, antibodies, buffers, nucleic acids, biological agents, assays, conjugation chemistries, and chemical groups for veterenary use; kits, comprising reagents, enzymes, enzyme substrates, monoclonal antibodies, buffers, nucleic acids, biological agents, and assays, for use in the fields of nucleic acid sequencing, proteomics, methylomics, metabolomics, diagnostics, diagnostic research, clinical research, drug development, pharmaceutical research, life sciences, exosomics, lipidomics, genetics, genomics, biotechnology, forensics, laboratory research, scientific research, medical research, oncology, neurodegeneration, infectious disease for scientific research
First Use Date in General
13th Oct 2021
First Use Date in Commerce
15th Nov 2021
Mark Details
Serial Number
No 97680953
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Dec 2024 | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED |
| 04th Dec 2024 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED |
| 04th Dec 2024 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED |
| 21st Nov 2024 | EX PARTE APPEAL-INSTITUTED |
| 21st Nov 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| 05th Nov 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
| 30th Oct 2024 | PETITION GRANTED - TTAB APPEAL FILED |
| 30th Oct 2024 | NOTICE OF REVIVAL - E-MAILED |
| 11th Oct 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
| 04th Oct 2024 | TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED |